Get the Stockscreener App
3.72
3.56%
-0.1372
Heartsciences Inc stock is traded at $3.72, with a volume of 51,860.
It is down -3.56% in the last 24 hours and up +14.11% over the past month.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
See More
Previous Close:
$3.8572
Open:
$3.96
24h Volume:
51,860
Relative Volume:
2.16
Market Cap:
$3.88M
Revenue:
-
Net Income/Loss:
$-7.29M
P/E Ratio:
-0.1527
EPS:
-24.3686
Net Cash Flow:
$-6.81M
1W Performance:
+3.62%
1M Performance:
+14.11%
6M Performance:
-3.38%
1Y Performance:
-29.68%
1-Day Range:
$3.6523
$4.07
1-Week Range:
$3.5001
$4.07
52-Week Range:
$2.36
$5.77
Heartsciences Inc Stock (HSCS) Company Profile
Name
Heartsciences Inc
Sector
Industry
Phone
682-237-7781
Address
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
3.72 | 3.88M | 0 | -7.29M | -6.81M | -24.37 |
|
ABT
Abbott Laboratories
|
132.28 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
SYK
Stryker Corp
|
373.37 | 147.15B | 23.22B | 2.86B | 3.58B | 7.40 |
|
BSX
Boston Scientific Corp
|
101.73 | 146.97B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
86.17 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
73.27 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Heartsciences Inc Stock (HSCS) Latest News
FDA Grants Breakthrough Device Designation for HeartSciences' AI-ECG Algorithm - Diagnostic and Interventional Cardiology
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis - Investing News Network
HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithm - MSN
HeartSciences (HSCS) Gains FDA Breakthrough Status for AI ECG Al - GuruFocus
Heart Test Laboratories Receives FDA Breakthrough Designation - TipRanks
HeartSciences (HSCS) Gains FDA Breakthrough Status for AI ECG Algorithm | HSCS Stock News - GuruFocus
Revolutionary AI Algorithm Detects Silent Killer Heart Disease 2 Years Earlier, FDA Fast-Tracks Approval - Stock Titan
Heart Test Laboratories Files Certificate for Preferred Stock - TipRanks
HeartSciences announces grant by USPTO for ECG assessment of heart function - TipRanks
HeartSciences Inc. Announces the Grant by the United States Patent and Trademark Office of A foundational Patent Covering the Establishing the Estimation of Echocardiography parameters Indicative of Heart Function Using an ECG - marketscreener.com
Heart Test Laboratories Secures Foundational Patent for AI-ECG - TipRanks
HeartSciences (HSCS) Strengthens IP Portfolio with New Patent Grant | HSCS Stock News - GuruFocus
HeartSciences Inc. Secures Foundational Patent for AI-Driven ECG Technology Enhancing Heart Function Detection - Nasdaq
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value - The Manila Times
Revolutionary AI Patent: HeartSciences Transforms ECG Technology for Earlier Heart Disease Detection - Stock Titan
HeartSciences signs first MyoVista Insights platform customer - Yahoo Finance
HeartSciences Inc. Signs First MyVista Insights Platform Customer - marketscreener.com
HeartSciences Signs First MyoVista Insights(TM) Platform Customer - marketscreener.com
HeartSciences (HSCS) Secures First Client for MyoVista Insights in the UK | HSCS Stock News - GuruFocus
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone - GlobeNewswire
HeartSciences amends corporate articles By Investing.com - Investing.com Canada
HeartSciences amends corporate articles - Investing.com
Heart Test Laboratories Announces $15M Securities Offering - TipRanks
Heart Test Labs Granted Nasdaq Compliance Extension - MSN
HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025 - The Manila Times
HeartSciences Unveils Game-Changing AI-Powered ECG Platform: CEO Presents Investment Opportunity Tomorrow - Stock Titan
HeartSciences receives Nasdaq compliance extension - Investing.com
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025Featuring CEO Andrew Simpson - The Manila Times
HeartSciences (HSCS) Enhances Team with Key Scientific Advisory Appointments | HSCS Stock News - GuruFocus
HeartSciences Inc. Expands Scientific Advisory Board with Three New Appointments to Enhance AI-Driven Cardiac Care - Nasdaq
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board - The Manila Times
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results - ADVFN
HeartSciences launches MyoVista Insights platform - TipRanks
HeartSciences (HSCS) Unveils MyoVista Insights Platform | HSCS S - GuruFocus
HeartSciences (HSCS) Unveils MyoVista Insights Platform | HSCS Stock News - GuruFocus
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program - The Manila Times
Lifestyle Icon Martha Stewart Confirmed As Vivid Sydney 2025's Global Storyteller - Barchart.com
This AI Company Is Solving A 100+ Year-Old Health Problem - Barchart.com
Northstar Secures 15-Year Lease Extension For Delta, BC Facility - Barchart.com
/R E P E A T -- LASSONDE INDUSTRIES INC. WILL HOLD A CONFERENCE CALL TO DISCUSS ITS Q4 AND FISCAL 2024 RESULTS/ - Barchart.com
HeartSciences faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada
HeartSciences faces Nasdaq delisting over equity shortfall - Investing.com
HeartSciences Reports Third Quarter Fiscal 2025 Financial Results and Business Update on AI-Powered ECG Innovations - Nasdaq
Heartsciences Inc Stock (HSCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):